Delivery Order SPE2DB24D3015-SPE2DB25FGAJE
- Not listed
- The Defense Logistics Agency awarded a $22,497.98 delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for TALTZ 80 mg/ml autoinjector supply. This is a firm fixed price, non-set-aside contract with a completion date of August 15, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- The Defense Logistics Agency awarded a delivery order valued at $5,055.05 to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector medication, valued at $3,320.62 with a firm fixed price structure. The award was made on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive, non-set-aside delivery order. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,519.43 to AmerisourceBergen Drug Corp for supply of TALTZ 80 mg/ml autoinjector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, issued on August 27, 2025, with an ultimate completion date of August 28, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,702.09 to AmerisourceBergen Drug Corp for TALTZ 80 mg/mL auto-injector 2-packs on July 15, 2025, with completion targeted for July 16, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling and runs through December 2026....
- The Defense Logistics Agency awarded a $3,346.05 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector on September 9, 2025, with completion targeted for September 10, 2025. This competitively awarded, firm fixed-price contract represents a pediatric delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. AmerisourceBergen, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $31,434.96 to AmerisourceBergen Drug Corp for TALTZ 80 MG/ML Autoinjector on September 23, 2025, with completion scheduled for September 24, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as a...
- The Defense Logistics Agency (DLA) awarded a $18,151.80 delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication, with a completion date of September 8, 2025. The contract was competitively awarded on September 5, 2025, with no set-aside designation, utilizing firm fixed-price terms. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $7,591.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector (2-pack), with an ultimate completion date of September 12, 2025. This non-set-aside contract represents a single-line pharmaceutical delivery under the company's broader federal supply relationships. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $10,041.90 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TALTZ 80 mg/ml autoinjector medication. The contract is classified as a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This delivery order was competitively awarded without set-aside designation and is scheduled for...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGAJEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TALTZ 80 mg/ml auto-injector medication with a ceiling value of $3,698.27. This non-set-aside, competitively awarded contract employs firm fixed price pricing and is scheduled for completion by July 31, 2025. The delivery order serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through its comprehensive pharmaceutical support vehicle. The company's extensive federal contract portfolio demonstrates its capability to supply a wide range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This delivery order for TALTZ, an autoinjector medication used in rheumatology and dermatology treatment, represents one of many pharmaceutical acquisitions supporting military and federal healthcare programs through DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 7/30/25 |